Table 2. Effectiveness and cost–effectiveness of pulse oximeters.
Parameter | Point estimate (range) |
Data source(s) and assumption | |
---|---|---|---|
Commercial tabletop device | Hand-held device | ||
Baseline anaesthetic-related mortality, deaths per million operations requiring general anaesthesia | 467 (253–7500) | 467 (253–7500) | Systematic review of anaesthetic-related mortality14 |
Anaesthetic-related deaths averted by oximetry, % | 10 (3–50) | 10 (3–50) | Authors’ estimates based on intermediate outcomes from systematic review of randomized control trials22 and observational data14,28,29 |
Discounted DALYs per death avoideda | 15.5 (10–30) | 15.5 (10–30) | Authors’ calculation based on approximation of age distribution of patients undergoing surgery36 and health-adjusted life expectancy by age35 |
Number of times each oximeter used per week | 22 (20–30) | 22 (20–30) | Assumed 80% utilization8 of maximum capacity of 25–30 operations per week12 |
Discounted DALYs averted per year of oximeter use | 0.83 | 0.83 | Authors’ calculation |
Equivalent annual cost of oximeter, US$b | 310 | 95 | See Table 1 |
Cost per DALY averted, US$c | 374 | 115 | Authors’ calculation |
DALY: disability-adjusted life-year; US$: United States dollars.
a Based on region-specific life-tables.
b From Table 1, in 2013 values.
c In 2013 values.